These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32189470)

  • 1. Novel stimulation strategy with autologous tumor cells to generate T cell receptor-engineered T cells in esophageal squamous cell carcinoma.
    Zhang L
    Thorac Cancer; 2020 May; 11(5):1117-1118. PubMed ID: 32189470
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma.
    Tan Q; Zhang C; Yang W; Liu Y; Heyilimu P; Feng D; Xing L; Ke Y; Lu Z
    J Immunother Cancer; 2019 Aug; 7(1):232. PubMed ID: 31462302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
    Zhang C; Huang H; Miao Y; Xiong H; Lu Z
    J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative Strategies.
    Alsina M; Moehler M; Lorenzen S
    Oncol Res Treat; 2018; 41(5):266-271. PubMed ID: 29705786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual TGF-β and PD-1 blockade synergistically enhances MAGE-A3-specific CD8
    Chen X; Wang L; Li P; Song M; Qin G; Gao Q; Zhang Z; Yue D; Wang D; Nan S; Qi Y; Li F; Yang L; Huang L; Zhang M; Zhang B; Gao Y; Zhang Y
    Int J Cancer; 2018 Nov; 143(10):2561-2574. PubMed ID: 29981155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative genome-scale analysis of immune infiltration in esophageal carcinoma.
    Bian Y; Bi G; Wei T; Yao G; Chen Z; Zhan C; Fan H
    Int Immunopharmacol; 2021 Apr; 93():107371. PubMed ID: 33535118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment.
    Zheng Y; Chen Z; Han Y; Han L; Zou X; Zhou B; Hu R; Hao J; Bai S; Xiao H; Li WV; Bueker A; Ma Y; Xie G; Yang J; Chen S; Li H; Cao J; Shen L
    Nat Commun; 2020 Dec; 11(1):6268. PubMed ID: 33293583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells in esophageal cancer and response to therapy.
    Harada K; Pool Pizzi M; Baba H; Shanbhag ND; Song S; Ajani JA
    Cancer; 2018 Oct; 124(20):3962-3964. PubMed ID: 30368777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
    Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
    Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus.
    Fassan M; Cavallin F; Guzzardo V; Kotsafti A; Scarpa M; Cagol M; Chiarion-Sileni V; Maria Saadeh L; Alfieri R; Castagliuolo I; Rugge M; Castoro C; Scarpa M
    Cancer Med; 2019 Oct; 8(13):6036-6048. PubMed ID: 31429521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High infiltration of B cells in tertiary lymphoid structures, TCR oligoclonality, and neoantigens are part of esophageal squamous cell carcinoma microenvironment.
    Barros LRC; Souza-Santos PT; Pretti MAM; Vieira GF; Bragatte MAS; Mendes MFA; De Freitas MV; Scherer NM; De Oliveira IM; Rapozo DCM; Fernandes PV; Simão TA; Soares-Lima SC; Boroni M; Ribeiro Pinto LF; Bonamino MH
    J Leukoc Biol; 2020 Oct; 108(4):1307-1318. PubMed ID: 32827331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A-to-I RNA-Editing: An Epigenetic Hallmark Cannot Be Ignored in Silencing the Tumor Microenvironment and Is Promising in Predicting Immunotherapy Response for Esophageal Squamous Cell Carcinoma.
    Wang S; Liu C; Zhang C; Xue L; Sun N; He J
    Gastroenterology; 2023 Jul; 165(1):275-278.e8. PubMed ID: 36990293
    [No Abstract]   [Full Text] [Related]  

  • 14. Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer.
    Kageyama S; Ikeda H; Miyahara Y; Imai N; Ishihara M; Saito K; Sugino S; Ueda S; Ishikawa T; Kokura S; Naota H; Ohishi K; Shiraishi T; Inoue N; Tanabe M; Kidokoro T; Yoshioka H; Tomura D; Nukaya I; Mineno J; Takesako K; Katayama N; Shiku H
    Clin Cancer Res; 2015 May; 21(10):2268-77. PubMed ID: 25855804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
    Gong L; Mao W; Chen Q; Jiang Y; Fan Y
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric antigen receptor--modified T cells: clinical translation in stem cell transplantation and beyond.
    Riddell SR; Jensen MC; June CH
    Biol Blood Marrow Transplant; 2013 Jan; 19(1 Suppl):S2-5. PubMed ID: 23085599
    [No Abstract]   [Full Text] [Related]  

  • 17. Immediate and substantial evolution of T-cell repertoire in peripheral blood and tumor microenvironment of patients with esophageal squamous cell carcinoma treated with preoperative chemotherapy.
    Zhang C; Palashati H; Tan Q; Ku W; Miao Y; Xiong H; Lu Z
    Carcinogenesis; 2018 Dec; 39(11):1389-1398. PubMed ID: 30202955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating exosomes from esophageal squamous cell carcinoma mediate the generation of B10 and PD-1
    Mao Y; Wang Y; Dong L; Zhang Q; Wang C; Zhang Y; Li X; Fu Z
    Cancer Sci; 2019 Sep; 110(9):2700-2710. PubMed ID: 31276257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and translational advances in esophageal squamous cell carcinoma.
    Reichenbach ZW; Murray MG; Saxena R; Farkas D; Karassik EG; Klochkova A; Patel K; Tice C; Hall TM; Gang J; Parkman HP; Ward SJ; Tétreault MP; Whelan KA
    Adv Cancer Res; 2019; 144():95-135. PubMed ID: 31349905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for esophageal squamous cell carcinoma: a review.
    Mimura K; Yamada L; Ujiie D; Hayase S; Tada T; Hanayama H; Thar Min AK; Shibata M; Momma T; Saze Z; Ohki S; Kono K
    Fukushima J Med Sci; 2018 Aug; 64(2):46-53. PubMed ID: 30058598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.